Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
2.
Sci Rep ; 10(1): 12060, 2020 07 21.
Article in English | MEDLINE | ID: mdl-32694738

ABSTRACT

Given the poor track record to date of animal models for creating cardioprotective drugs, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have been proposed as a therapeutically relevant human platform to guide target validation and cardiac drug development. Mitogen-Activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4) is an "upstream" member of the MAPK superfamily that is implicated in human cardiac muscle cell death from oxidative stress, based on gene silencing and pharmacological inhibition in hPSC-CMs. A further role for MAP4K4 was proposed in heart muscle cell death triggered by cardiotoxic anti-cancer drugs, given its reported activation in failing human hearts with doxorubicin (DOX) cardiomyopathy, and its activation acutely by DOX in cultured cardiomyocytes. Here, we report successful protection from DOX in two independent hPSC-CM lines, using two potent, highly selective MAP4K4 inhibitors. The MAP4K4 inhibitors enhanced viability and reduced apoptosis at otherwise lethal concentrations of DOX, and preserved cardiomyocyte function, as measured by spontaneous calcium transients, at sub-maximal ones. Notably, in contrast, no intereference was seen in tumor cell killing, caspase activation, or mitochondrial membrane dissipation by DOX, in human cancer cell lines. Thus, MAP4K4 is a plausible, tractable, selective therapeutic target in DOX-induced human heart muscle cell death.


Subject(s)
Cardiotonic Agents/pharmacology , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Anthracyclines/adverse effects , Antineoplastic Agents/adverse effects , Apoptosis/drug effects , Calcium , Cardiotoxicity/etiology , Cell Differentiation/drug effects , Cell Line , Doxorubicin/pharmacology , Humans , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism
3.
Med Dosim ; 41(4): 329-333, 2016.
Article in English | MEDLINE | ID: mdl-27765542

ABSTRACT

Various radiotherapy planning methods for T1N0 laryngeal cancer have been proposed to decrease normal tissue toxicity. We compare helical tomotherapy (HT), linac-based intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT), and 3-D conformal radiotherapy (3D-CRT) techniques for T1N0 laryngeal cancer. Overall, 10 patients with T1N0 laryngeal cancer were selected and evaluated. Furthermore, 10 radiotherapy treatment plans have been created for all 10 patients, including HT, IMRT, VMAT, and 3D-CRT. IMRT, VMAT, and HT plans vs 3D-CRT plans consistently provided superior planning target volume (PTV) coverage. Similar target coverage was observed between the 3 IMRT modalities. Compared with 3D-CRT, IMRT, HT, and VMAT significantly reduced the mean dose to the carotid arteries. VMAT resulted in the lowest mean dose to the submandibular and thyroid glands. Compared with 3D-CRT, IMRT, HT, and VMAT significantly increased the maximum dose to the spinal cord It was observed that the 3 IMRT modalities studied showed superior target coverage with less variation between each plan in comparison with 3D-CRT. The 3D-CRT plans performed better at the Dmax of the spinal cord. Clinical investigation is warranted to determine if these treatment approaches would translate into a reduction in radiation therapy-induced toxicities.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Glottis , Laryngeal Neoplasms/radiotherapy , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/methods , Radiotherapy, Intensity-Modulated/methods , Carcinoma, Squamous Cell/pathology , Humans , Laryngeal Neoplasms/pathology , Neoplasm Staging , Radiotherapy Dosage
4.
J Magn Reson Imaging ; 44(4): 1020-30, 2016 10.
Article in English | MEDLINE | ID: mdl-26971387

ABSTRACT

PURPOSE: To assess whether R2* mapping with a standard Monoexponential (ME) or a Gaussian Augmentation of the Monoexponential (GAME) decay model better characterizes gradient-echo signal decays in gynecological cancers after external beam radiation therapy at 3T, and evaluate implications of modeling for noninvasive identification of intratumoral hypoxia. MATERIALS AND METHODS: Multi-gradient-echo signals were acquired on 25 consecutive patients with gynecologic cancers and three healthy participants during inhalation of different oxygen concentrations at 3T. Data were fitted with both ME and GAME models. Models were compared using F-tests in tumors and muscles in patients, muscles, cervix, and uterus in healthy participants, and across oxygenation levels. RESULTS: GAME significantly improved fitting over ME (P < 0.05): Improvements with GAME covered 34% of tumor regions-of-interest on average, ranging from 6% (of a vaginal tumor) to 68% (of a cervical tumor) in individual tumors. Improvements with GAME were more prominent in areas that would be assumed hypoxic based on ME alone, reaching 90% as ME R2* approached 100 Hz. Gradient echo decay parameters at different oxygenation levels were not significantly different (P = 0.81). CONCLUSION: R2* may prove sensitive to hypoxia; however, inaccurate representations of underlying data may limit the success of quantitative assessments. Although the degree to which R2 or σ values correlate with hypoxia remains unknown, improved characterization with GAME increases the potential for determining any correlates of fit parameters with biomarkers, such as oxygenation status. J. MAGN. RESON. IMAGING 2016;44:1020-1030.


Subject(s)
Biomarkers, Tumor/metabolism , Genital Neoplasms, Female/diagnostic imaging , Genital Neoplasms, Female/metabolism , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Models, Statistical , Oxygen/metabolism , Adult , Aged , Computer Simulation , Female , Humans , Image Enhancement/methods , Middle Aged , Normal Distribution , Reproducibility of Results , Sensitivity and Specificity , Tumor Hypoxia
5.
Heredity (Edinb) ; 116(5): 458-65, 2016 May.
Article in English | MEDLINE | ID: mdl-26837273

ABSTRACT

Encephalitozoon cuniculi is a model microsporidian species with a mononucleate nucleus and a genome that has been extensively studied. To date, analyses of genome diversity have revealed the existence of four genotypes in E. cuniculi (EcI, II, III and IV). Genome sequences are available for EcI, II and III, and are all very divergent, possibly diploid and genetically homogeneous. The mechanisms that cause low genetic diversity in E. cuniculi (for example, selfing, inbreeding or a combination of both), as well as the degree of genetic variation in their natural populations, have been hard to assess because genome data have been so far gathered from laboratory-propagated strains. In this study, we aim to tackle this issue by analyzing the complete genome sequence of a natural strain of E. cuniculi isolated in 2013 from a steppe lemming. The strain belongs to the EcIII genotype and has been designated EcIII-L. The EcIII-L genome sequence harbors genomic features intermediate to known genomes of II and III lab strains, and we provide primers that differentiate the three E. cuniculi genotypes using a single PCR. Surprisingly, the EcIII-L genome is also highly homogeneous, harbors signatures of heterozygosity and also one strain-specific single-nucleotide polymorphism (SNP) that introduces a stop codon in a key meiosis gene, Spo11. Functional analyses using a heterologous system demonstrate that this SNP leads to a deficient meiosis in a model fungus. This indicates that EcIII-L meiotic machinery may be presently broken. Overall, our findings reveal previously unsuspected genome diversity in E. cuniculi, some of which appears to affect genes of primary importance for the biology of this pathogen.


Subject(s)
Arvicolinae/microbiology , Encephalitozoon cuniculi/genetics , Genetic Variation , Genome, Fungal , Animals , Chromosome Mapping , DNA, Fungal/genetics , Genotype , Heterozygote , Meiosis , Polymorphism, Single Nucleotide , Sequence Analysis, DNA
6.
Saudi Med J ; 25(12): 1835-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15711650

ABSTRACT

OBJECTIVE: The aim of this preliminary study is to investigate the effects of exogenous Endothelin-1 (ET-1) on systolic blood pressure and heart rate as well as on plasma nitric oxide metabolites, malondialdehyde, copper and zinc concentrations and red cell superoxide dismutase and catalase activities. METHODS: Thirty Wistar-Albino male rats, 8-10 weeks old, with a mean body weight of 285 gm were used in the study. Daily systolic blood pressures were measured by tail plethysmography. Following exogenous administration of ET-1 (1 nmol/kg) systolic arterial blood pressures were recorded and blood samples of control and experimental groups were drawn. Nitric oxide metabolites (nitrite, nitrate), malondialdehyde, copper, zinc concentrations in plasma, superoxide dismutase and catalase activities and copper, zinc concentrations in red cell were determined both in control and experimental groups. All laboratory procedures were performed at the Department of Pathophysiology, School of Medicine, Ankara University, Ankara, Turkey in 2003. RESULTS: There were statistically significant increases in plasma nitrate, red cell superoxide dismutase activity, systolic arterial blood pressure and statistically significant decreases in red cell catalase activity, plasma copper, red cell zinc concentrations in experimental group due to exogenous ET-1 administration compared to controls. CONCLUSION: There appears an important interaction between exogenous ET-1 and oxidative-nitrosative stress markers which may affect the progression of hypertension.


Subject(s)
Endothelin-1/pharmacology , Nitric Oxide/blood , Oxidative Stress/drug effects , Animals , Catalase/blood , Copper/blood , Erythrocytes/drug effects , Heart Rate/drug effects , Hypertension/enzymology , Male , Malondialdehyde/blood , Nitrosation , Rats , Rats, Wistar , Superoxide Dismutase/blood , Zinc/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...